DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Escudier B. et al.
Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival.
J Clin Oncol 2010;
28: 2144-2150
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.